Replies to post #820006 on NorthWest Biotherapeutics Inc (NWBO)

[sage007]

The guidance etc is too far away. I am just looking at approval for L. The price post that might not improve much as the stock is still on OTC and bashing will continue to keep the price suppressed. To even think about revenues from Direct is just wishful thinking. It shouldn’t even be on the horizon of any sensible investor. Execution of L and reaping revenues from that will determine the future and overall growth of this company. It would be at least 3 years, if not longer, post this first approval, for Direct to even be thought of as a revenue generator.

[AngeloFoca]

First Berlin analyst guessed at 7 cents per share in 2027

So... 1,600,000,000 shares x $0.07 per share = $112,000,000 Profit.

$112 Million Profit = Approximately $200 Million Revenue.

Novocure hit a high of $21 Billion Market Cap, on $200 Million Revenue, a few years back.

.